Cross Country Healthcare, Inc.
NASDAQ:CCRN
14.16 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,019.728 | 2,806.609 | 1,676.652 | 836.417 | 822.224 | 816.484 | 865.048 | 833.537 | 767.421 | 617.825 | 438.311 | 442.635 | 503.986 | 468.562 | 578.237 | 734.247 | 718.272 | 655.152 | 645.393 | 654.111 | 686.93 | 639.953 | 500.503 | 367.69 | 193.774 |
| Cost of Revenue
| 1,587.665 | 2,178.923 | 1,301.653 | 633.685 | 618.215 | 606.921 | 636.462 | 611.802 | 570.056 | 460.021 | 324.851 | 331.05 | 366.044 | 336.25 | 420.856 | 541.66 | 543.608 | 502.468 | 503.103 | 509.57 | 519.96 | 478.55 | 374.651 | 273.094 | 148.223 |
| Gross Profit
| 432.063 | 627.686 | 374.999 | 202.732 | 204.009 | 209.563 | 228.586 | 221.735 | 197.365 | 157.804 | 113.46 | 111.585 | 137.942 | 132.312 | 157.381 | 192.587 | 174.664 | 152.684 | 142.29 | 144.54 | 166.97 | 161.403 | 125.851 | 94.595 | 45.551 |
| Gross Profit Ratio
| 0.214 | 0.224 | 0.224 | 0.242 | 0.248 | 0.257 | 0.264 | 0.266 | 0.257 | 0.255 | 0.259 | 0.252 | 0.274 | 0.282 | 0.272 | 0.262 | 0.243 | 0.233 | 0.22 | 0.221 | 0.243 | 0.252 | 0.251 | 0.257 | 0.235 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 303.453 | 308.109 | 205.792 | 167.609 | 174.059 | 180.23 | 187.435 | 179.82 | 161.275 | 141.018 | 106.867 | 109.417 | 116.538 | 108.984 | 0.345 | 137.766 | 124.251 | 110.631 | 105.975 | 100.493 | 110.895 | 95.172 | 69.666 | 49.46 | 21.945 |
| Selling & Marketing Expenses
| 11.5 | 16.1 | 9.5 | 6.2 | 7.9 | 6.7 | 7.6 | 10.2 | 4.9 | 4.1 | -0.75 | 0 | -0 | 0 | 124.473 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 314.953 | 324.209 | 215.292 | 173.809 | 181.959 | 180.23 | 187.435 | 179.82 | 161.275 | 141.018 | 106.117 | 109.417 | 116.538 | 108.984 | 124.818 | 137.766 | 124.251 | 110.631 | 105.975 | 100.493 | 110.895 | 95.172 | 69.666 | 49.46 | 21.945 |
| Other Expenses
| -0.002 | 12.576 | 9.852 | 12.671 | 14.075 | 0.418 | 0.155 | 0.23 | 0.306 | 0.03 | 0.119 | -0.016 | 10.863 | 12.188 | 12.791 | 254.897 | 8.395 | 13.876 | 6.582 | 7.485 | 8.094 | 7.558 | 17.737 | 16.314 | 154.176 |
| Operating Expenses
| 314.953 | 336.785 | 225.144 | 186.48 | 196.034 | 192.01 | 197.609 | 189.002 | 169.341 | 148.459 | 112.297 | 116.585 | 127.401 | 121.172 | 137.954 | 392.663 | 132.645 | 124.508 | 112.557 | 107.977 | 118.989 | 102.73 | 87.403 | 65.774 | 176.121 |
| Operating Income
| 117.11 | 273.108 | 139.304 | 15.972 | 8.043 | -12.88 | 11.748 | 6.184 | 20.565 | -10.468 | -8.022 | -24.518 | 10.541 | 0.376 | 17.701 | -200.076 | 42.019 | 28.176 | 29.733 | 36.563 | 47.981 | 58.673 | 38.449 | 28.821 | 17.653 |
| Operating Income Ratio
| 0.058 | 0.097 | 0.083 | 0.019 | 0.01 | -0.016 | 0.014 | 0.007 | 0.027 | -0.017 | -0.018 | -0.055 | 0.021 | 0.001 | 0.031 | -0.272 | 0.059 | 0.043 | 0.046 | 0.056 | 0.07 | 0.092 | 0.077 | 0.078 | 0.091 |
| Total Other Income Expenses Net
| -14.216 | -16.783 | -6.096 | -28.302 | -32.254 | -30.094 | -22.462 | -22.082 | -17.054 | -36.503 | -10.353 | -19.554 | 0.545 | -10.84 | -1.599 | -243.962 | -0.127 | -6.858 | -1.359 | -4.025 | -0.976 | -0.886 | -14.422 | -1.289 | -5.241 |
| Income Before Tax
| 102.894 | 256.325 | 133.208 | -12.33 | -24.211 | -18.195 | 4.301 | 4.545 | 4.16 | -31.318 | -10.039 | -26.895 | 8.23 | -3.772 | 11.654 | -204.168 | 39.339 | 26.712 | 24.916 | 32.538 | 42.701 | 54.92 | 24.027 | 13.386 | 12.412 |
| Income Before Tax Ratio
| 0.051 | 0.091 | 0.079 | -0.015 | -0.029 | -0.022 | 0.005 | 0.005 | 0.005 | -0.051 | -0.023 | -0.061 | 0.016 | -0.008 | 0.02 | -0.278 | 0.055 | 0.041 | 0.039 | 0.05 | 0.062 | 0.086 | 0.048 | 0.036 | 0.064 |
| Income Tax Expense
| 30.263 | 67.864 | 1.206 | -0.188 | 31.732 | -2.478 | -34.501 | -4.186 | -0.794 | 0.216 | 26.827 | -6.15 | 4.132 | -0.997 | 4.96 | -61.224 | 14.759 | 10.146 | 9.575 | 11.936 | 16.525 | 21.254 | 10.364 | 6.73 | 0.672 |
| Net Income
| 72.631 | 188.461 | 132.002 | -12.142 | -55.943 | -16.951 | 37.513 | 7.967 | 4.418 | -31.783 | -34.585 | -42.221 | 4.098 | -2.775 | 6.694 | -142.945 | 24.58 | 16.636 | 14.752 | 20.659 | 25.821 | 29.783 | 8.672 | 4.598 | 11.545 |
| Net Income Ratio
| 0.036 | 0.067 | 0.079 | -0.015 | -0.068 | -0.021 | 0.043 | 0.01 | 0.006 | -0.051 | -0.079 | -0.095 | 0.008 | -0.006 | 0.012 | -0.195 | 0.034 | 0.025 | 0.023 | 0.032 | 0.038 | 0.047 | 0.017 | 0.013 | 0.06 |
| EPS
| 2.07 | 5.09 | 3.6 | -0.34 | -1.56 | -0.48 | 1.07 | 0.25 | 0.14 | -1.02 | -1.12 | -1.37 | 0.13 | -0.089 | 0.22 | -4.64 | 0.77 | 0.52 | 0.46 | 0.65 | 0.8 | 0.92 | 0.35 | 0.2 | 0.75 |
| EPS Diluted
| 2.05 | 5.02 | 3.53 | -0.34 | -1.56 | -0.48 | 1.01 | 0.15 | 0.14 | -1.02 | -1.12 | -1.37 | 0.13 | -0.089 | 0.22 | -4.61 | 0.76 | 0.51 | 0.45 | 0.63 | 0.79 | 0.88 | 0.34 | 0.2 | 0.75 |
| EBITDA
| 135.457 | 304.813 | 160.477 | 28.643 | 22.118 | 29.751 | 41.306 | 42.145 | 36.396 | 16.816 | 7.462 | 2.152 | 20.825 | 23.034 | 32.218 | 54.689 | 50.657 | 42.2 | 38.64 | 44.11 | 57.082 | 66.231 | 56.185 | 45.135 | -125.285 |
| EBITDA Ratio
| 0.067 | 0.109 | 0.096 | 0.034 | 0.027 | 0.036 | 0.048 | 0.051 | 0.047 | 0.027 | 0.017 | 0.005 | 0.041 | 0.049 | 0.056 | 0.074 | 0.071 | 0.064 | 0.06 | 0.067 | 0.083 | 0.103 | 0.112 | 0.123 | -0.647 |